LONDON, Jan. 20, 2021 /PRNewswire/ —This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important information” at the end of this announcement and in the offer document which will be published shortly before the commencement of the acceptance period under the Offer. Shareholders in the United States should also refer to the section titled “Special notice to shareholders in the United States” at the end of this announcement.

On 7 January 2021, Entain plc, through its wholly-owned subsidiary Bwin Holdings (Malta) Limited (“Entain“) announced a recommended public cash offer to the shareholders of Enlabs AB (publ) (“Enlabs“) to tender all their Enlabs shares to Entain (the “Offer“). The Enlabs shareholders are offered SEK 40 in cash per share (the “Offer Price“). The Enlabs shares are admitted to trading on Nasdaq First North Growth Market of Sweden.

The offer document in respect of the Offer and the acceptance form are available on Entain’s website and on the website of Aktieinvest FK AB

A copy of the offer document and a pre-printed acceptance form will be sent to shareholders in Enlabs whose shares are directly registered with Euroclear Sweden AB, except for those domiciled in the excluded jurisdictions (see above).

The acceptance period of the Offer commences on 21 January 2021 and expires on 18 February 2021. Settlement is expected to commence on 2 March 2021. Entain has reserved the right to extend the acceptance period as well as to postpone the date of settlement.

Information about the Offer is made available at